• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Imunon, Inc. - Common Stock (NQ:IMNN)

    3.560 -0.130 (-3.52%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Imunon, Inc. - Common Stock

    News headline image
    Life Sciences Investor Forum: Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    IMUNON Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    Life Sciences Investor Forum Agenda Announced for June 11th-12th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical Proof of Concept and Key Competitive Advantages
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    IMUNON to Participate in the A.G.P./Alliance Global Partners Virtual Biotech Conference on November 30, 2022 – December 1, 2022
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    IMUNON Announces Strategic Investment in Transomic Technologies
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    Imunon to Hold Third Quarter 2022 Financial Results and Business Update Conference Call on Monday, November 14, 2022
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    Imunon Appoints James E. Dentzer to its Board of Directors
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    Imunon Reports Partial Results from Ongoing Non-human Primate Study
    From Imunon, Inc.
    Via GlobeNewswire
    News headline image
    Imunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
    From Imunon, Inc.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.